TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adoptive Cellular Immunotherapy
1.2 Key Market Segments
1.2.1 Adoptive Cellular Immunotherapy Segment by Type
1.2.2 Adoptive Cellular Immunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adoptive Cellular Immunotherapy Market Overview
2.1 Global Market Overview
2.1.1 Global Adoptive Cellular Immunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adoptive Cellular Immunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adoptive Cellular Immunotherapy Market Competitive Landscape
3.1 Global Adoptive Cellular Immunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adoptive Cellular Immunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adoptive Cellular Immunotherapy Sales Sites, Area Served, Product Type
3.6 Adoptive Cellular Immunotherapy Market Competitive Situation and Trends
3.6.1 Adoptive Cellular Immunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adoptive Cellular Immunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adoptive Cellular Immunotherapy Industry Chain Analysis
4.1 Adoptive Cellular Immunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adoptive Cellular Immunotherapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adoptive Cellular Immunotherapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adoptive Cellular Immunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Adoptive Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Adoptive Cellular Immunotherapy Price by Type (2019-2024)
7 Adoptive Cellular Immunotherapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adoptive Cellular Immunotherapy Market Sales by Application (2019-2024)
7.3 Global Adoptive Cellular Immunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Adoptive Cellular Immunotherapy Sales Growth Rate by Application (2019-2024)
8 Adoptive Cellular Immunotherapy Market Segmentation by Region
8.1 Global Adoptive Cellular Immunotherapy Sales by Region
8.1.1 Global Adoptive Cellular Immunotherapy Sales by Region
8.1.2 Global Adoptive Cellular Immunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Adoptive Cellular Immunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adoptive Cellular Immunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adoptive Cellular Immunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adoptive Cellular Immunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adoptive Cellular Immunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen Inc
9.1.1 Amgen Inc Adoptive Cellular Immunotherapy Basic Information
9.1.2 Amgen Inc Adoptive Cellular Immunotherapy Product Overview
9.1.3 Amgen Inc Adoptive Cellular Immunotherapy Product Market Performance
9.1.4 Amgen Inc Business Overview
9.1.5 Amgen Inc Adoptive Cellular Immunotherapy SWOT Analysis
9.1.6 Amgen Inc Recent Developments
9.2 Autolus Therapeutics Plc
9.2.1 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Basic Information
9.2.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Overview
9.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Market Performance
9.2.4 Autolus Therapeutics Plc Business Overview
9.2.5 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy SWOT Analysis
9.2.6 Autolus Therapeutics Plc Recent Developments
9.3 Beijing Immunochina Medical Science and Technology Co Ltd
9.3.1 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.3.2 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.3.3 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.3.4 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy SWOT Analysis
9.3.5 Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
9.3.6 Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
9.4 Bellicum Pharmaceuticals Inc
9.4.1 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Basic Information
9.4.2 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Overview
9.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Market Performance
9.4.4 Bellicum Pharmaceuticals Inc Business Overview
9.4.5 Bellicum Pharmaceuticals Inc Recent Developments
9.5 Bristol-Myers Squibb Co
9.5.1 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Basic Information
9.5.2 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Overview
9.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Market Performance
9.5.4 Bristol-Myers Squibb Co Business Overview
9.5.5 Bristol-Myers Squibb Co Recent Developments
9.6 bluebird bio Inc
9.6.1 bluebird bio Inc Adoptive Cellular Immunotherapy Basic Information
9.6.2 bluebird bio Inc Adoptive Cellular Immunotherapy Product Overview
9.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Product Market Performance
9.6.4 bluebird bio Inc Business Overview
9.6.5 bluebird bio Inc Recent Developments
9.7 CARsgen Therapeutics Ltd
9.7.1 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Basic Information
9.7.2 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Overview
9.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.7.4 CARsgen Therapeutics Ltd Business Overview
9.7.5 CARsgen Therapeutics Ltd Recent Developments
9.8 Celgene Corp
9.8.1 Celgene Corp Adoptive Cellular Immunotherapy Basic Information
9.8.2 Celgene Corp Adoptive Cellular Immunotherapy Product Overview
9.8.3 Celgene Corp Adoptive Cellular Immunotherapy Product Market Performance
9.8.4 Celgene Corp Business Overview
9.8.5 Celgene Corp Recent Developments
9.9 Cell Medica Ltd
9.9.1 Cell Medica Ltd Adoptive Cellular Immunotherapy Basic Information
9.9.2 Cell Medica Ltd Adoptive Cellular Immunotherapy Product Overview
9.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.9.4 Cell Medica Ltd Business Overview
9.9.5 Cell Medica Ltd Recent Developments
9.10 Cellular Biomedicine Group Inc
9.10.1 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Basic Information
9.10.2 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Overview
9.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Market Performance
9.10.4 Cellular Biomedicine Group Inc Business Overview
9.10.5 Cellular Biomedicine Group Inc Recent Developments
9.11 Celularity Inc
9.11.1 Celularity Inc Adoptive Cellular Immunotherapy Basic Information
9.11.2 Celularity Inc Adoptive Cellular Immunotherapy Product Overview
9.11.3 Celularity Inc Adoptive Cellular Immunotherapy Product Market Performance
9.11.4 Celularity Inc Business Overview
9.11.5 Celularity Inc Recent Developments
9.12 Celyad SA
9.12.1 Celyad SA Adoptive Cellular Immunotherapy Basic Information
9.12.2 Celyad SA Adoptive Cellular Immunotherapy Product Overview
9.12.3 Celyad SA Adoptive Cellular Immunotherapy Product Market Performance
9.12.4 Celyad SA Business Overview
9.12.5 Celyad SA Recent Developments
9.13 Daiichi Sankyo Co Ltd
9.13.1 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.13.2 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.13.4 Daiichi Sankyo Co Ltd Business Overview
9.13.5 Daiichi Sankyo Co Ltd Recent Developments
9.14 Fosun Pharmaceutical AG
9.14.1 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Basic Information
9.14.2 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Overview
9.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Market Performance
9.14.4 Fosun Pharmaceutical AG Business Overview
9.14.5 Fosun Pharmaceutical AG Recent Developments
9.15 Gilead Sciences Inc
9.15.1 Gilead Sciences Inc Adoptive Cellular Immunotherapy Basic Information
9.15.2 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Overview
9.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Market Performance
9.15.4 Gilead Sciences Inc Business Overview
9.15.5 Gilead Sciences Inc Recent Developments
9.16 Guangzhou Anjie Biomedical Technology Co Ltd
9.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
9.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
9.17 Hangzhou Converd Co Ltd
9.17.1 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.17.2 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.17.4 Hangzhou Converd Co Ltd Business Overview
9.17.5 Hangzhou Converd Co Ltd Recent Developments
9.18 Hebei Senlang Biotechnology Inc Ltd
9.18.1 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Basic Information
9.18.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Overview
9.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.18.4 Hebei Senlang Biotechnology Inc Ltd Business Overview
9.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
9.19 HRAIN Biotechnology Co Ltd
9.19.1 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.19.2 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.19.4 HRAIN Biotechnology Co Ltd Business Overview
9.19.5 HRAIN Biotechnology Co Ltd Recent Developments
9.20 Juno Therapeutics Inc
9.20.1 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Basic Information
9.20.2 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Overview
9.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Market Performance
9.20.4 Juno Therapeutics Inc Business Overview
9.20.5 Juno Therapeutics Inc Recent Developments
9.21 Kite Pharma Inc
9.21.1 Kite Pharma Inc Adoptive Cellular Immunotherapy Basic Information
9.21.2 Kite Pharma Inc Adoptive Cellular Immunotherapy Product Overview
9.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Product Market Performance
9.21.4 Kite Pharma Inc Business Overview
9.21.5 Kite Pharma Inc Recent Developments
9.22 Nanjing Legend Biotech Co Ltd
9.22.1 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.22.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.22.4 Nanjing Legend Biotech Co Ltd Business Overview
9.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
9.23 NantKwest Inc
9.23.1 NantKwest Inc Adoptive Cellular Immunotherapy Basic Information
9.23.2 NantKwest Inc Adoptive Cellular Immunotherapy Product Overview
9.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Product Market Performance
9.23.4 NantKwest Inc Business Overview
9.23.5 NantKwest Inc Recent Developments
9.24 Nkarta Inc
9.24.1 Nkarta Inc Adoptive Cellular Immunotherapy Basic Information
9.24.2 Nkarta Inc Adoptive Cellular Immunotherapy Product Overview
9.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Product Market Performance
9.24.4 Nkarta Inc Business Overview
9.24.5 Nkarta Inc Recent Developments
9.25 Novartis AG
9.25.1 Novartis AG Adoptive Cellular Immunotherapy Basic Information
9.25.2 Novartis AG Adoptive Cellular Immunotherapy Product Overview
9.25.3 Novartis AG Adoptive Cellular Immunotherapy Product Market Performance
9.25.4 Novartis AG Business Overview
9.25.5 Novartis AG Recent Developments
9.26 Ono Pharmaceutical Co Ltd
9.26.1 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.26.2 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.26.4 Ono Pharmaceutical Co Ltd Business Overview
9.26.5 Ono Pharmaceutical Co Ltd Recent Developments
9.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
9.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
9.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
9.28 Sorrento Therapeutics Inc
9.28.1 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Basic Information
9.28.2 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Overview
9.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Market Performance
9.28.4 Sorrento Therapeutics Inc Business Overview
9.28.5 Sorrento Therapeutics Inc Recent Developments
9.29 Takara Bio Inc
9.29.1 Takara Bio Inc Adoptive Cellular Immunotherapy Basic Information
9.29.2 Takara Bio Inc Adoptive Cellular Immunotherapy Product Overview
9.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Product Market Performance
9.29.4 Takara Bio Inc Business Overview
9.29.5 Takara Bio Inc Recent Developments
10 Adoptive Cellular Immunotherapy Market Forecast by Region
10.1 Global Adoptive Cellular Immunotherapy Market Size Forecast
10.2 Global Adoptive Cellular Immunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adoptive Cellular Immunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Adoptive Cellular Immunotherapy Market Size Forecast by Region
10.2.4 South America Adoptive Cellular Immunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adoptive Cellular Immunotherapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adoptive Cellular Immunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adoptive Cellular Immunotherapy by Type (2025-2030)
11.1.2 Global Adoptive Cellular Immunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adoptive Cellular Immunotherapy by Type (2025-2030)
11.2 Global Adoptive Cellular Immunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Adoptive Cellular Immunotherapy Sales (K Units) Forecast by Application
11.2.2 Global Adoptive Cellular Immunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings